- Home
- CTSO vs ONEG Comparison
CTSO vs ONEG Comparison
Compare CTSO & ONEG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTSO
- ONEG
- Stock Information
- Founded
- CTSO 1997
- ONEG 2021
- Country
- CTSO United States
- ONEG Hong Kong
- Employees
- CTSO N/A
- ONEG N/A
- Industry
- CTSO Medical/Dental Instruments
- ONEG Homebuilding
- Sector
- CTSO Health Care
- ONEG Consumer Discretionary
- Exchange
- CTSO Nasdaq
- ONEG Nasdaq
- Market Cap
- CTSO 52.6M
- ONEG 43.3M
- IPO Year
- CTSO N/A
- ONEG 2024
- Fundamental
- Price
- CTSO $1.03
- ONEG $7.59
- Analyst Decision
- CTSO Buy
- ONEG
- Analyst Count
- CTSO 2
- ONEG 0
- Target Price
- CTSO $5.50
- ONEG N/A
- AVG Volume (30 Days)
- CTSO 134.9K
- ONEG 572.1K
- Earning Date
- CTSO 08-12-2025
- ONEG 01-01-0001
- Dividend Yield
- CTSO N/A
- ONEG N/A
- EPS Growth
- CTSO N/A
- ONEG N/A
- EPS
- CTSO N/A
- ONEG 0.12
- Revenue
- CTSO $35,332,238.00
- ONEG $60,903,000.00
- Revenue This Year
- CTSO $18.34
- ONEG N/A
- Revenue Next Year
- CTSO $19.82
- ONEG N/A
- P/E Ratio
- CTSO N/A
- ONEG $59.29
- Revenue Growth
- CTSO 15.37
- ONEG 16.46
- 52 Week Low
- CTSO $0.71
- ONEG $1.48
- 52 Week High
- CTSO $1.61
- ONEG $10.80
- Technical
- Relative Strength Index (RSI)
- CTSO 49.00
- ONEG N/A
- Support Level
- CTSO $0.93
- ONEG N/A
- Resistance Level
- CTSO $1.39
- ONEG N/A
- Average True Range (ATR)
- CTSO 0.13
- ONEG 0.00
- MACD
- CTSO -0.02
- ONEG 0.00
- Stochastic Oscillator
- CTSO 34.92
- ONEG 0.00
About CTSO Cytosorbents Corporation
CytoSorbents Corp specializes in treating life-threatening conditions in intensive care and cardiac surgery using proprietary polymer adsorption technology. Its flagship product, CytoSorb, is approved in the EU as an extracorporeal cytokine absorber, aiming to reduce inflammation and prevent multiple organ failure in critical illnesses like sepsis and trauma. Revenue primarily comes from product sales in Germany, with additional income from grant agencies in the United States. The company operates through Direct sales and Distributors/strategic partners in United States, Germany and Other Countries. The company's product consists of Cytosorb, ECOS-300CY, VetResQ, HemoDefend, and DrugSorb-ATR.
About ONEG OneConstruction Group Limited Ordinary Shares
OneConstruction Group Ltd is a structural steelwork contractor in Hong Kong. It is engaged in the procurement and installation of structural steel for construction projects in Hong Kong. Its construction project include performing site preparatory and preliminary works, developing detailed work schedules and work allocation plans, implementing construction site works, and conducting site safety supervision and quality control.